SEC Form 4 · accession 0001127602-16-049053
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Davide Molho
Officer — Corporate Executive VP
Period of report
Apr 6, 2016
Accepted (ET)
Apr 8, 2016 · 7:05 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 6, 2016 | M | 11,075 | $36.25 | A | 79,008 | D | |
| Common Stock | Apr 6, 2016 | M | 8,588 | $37.03 | A | 67,933 | D | |
| Common Stock | Apr 6, 2016 | M | 11,004 | $40.40 | A | 90,012 | D | |
| Common Stock | Apr 6, 2016 | S | 30,667 | $80.00 | D | 59,345 | D | |
| Common Stock | holding | — | — | — | 574 | I | By Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $36.25 | Apr 6, 2016 | M | 11,075 | D | Feb 24, 2013 | Feb 24, 2019 | Common Stock | 11,075 | 0 | D |
| Stock Options (Right to Buy) | $37.03 | Apr 6, 2016 | M | 8,588 | D | Feb 25, 2012 | Feb 25, 2018 | Common Stock | 8,588 | 0 | D |
| Stock Options (Right to Buy) | $40.40 | Apr 6, 2016 | M | 11,004 | D | Feb 22, 2014 | Feb 22, 2020 | Common Stock | 11,004 | 11,004 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.